hrvatski glasnik intelektualnog vlasništva 05/2005 - Državni zavod ...
hrvatski glasnik intelektualnog vlasništva 05/2005 - Državni zavod ...
hrvatski glasnik intelektualnog vlasništva 05/2005 - Državni zavod ...
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
1978 HR - Patenti. - Hrvatski <strong>glasnik</strong> <strong>intelektualnog</strong> vlasništva 12, 20<strong>05</strong>, 5, 1897 – 2089<br />
opcionalno biti supstituirana; R 5 i -A-R 6 uzeti zajedno s atomom dušika,<br />
na kojeg su vezani mogu također formirati Het 1 ili Het 2 , R 12 je H, -NH 3 , -<br />
NR 5 AR 6 , C 1-6 alkil ili alkil-W-R 14 , gdje navedeni alkil je opcionalno<br />
supstituiran s halogenom, hidroksidom, arilom, heteroarilom, Het 1 , Het 2 ,<br />
ili aminom, gdje navedena amino grupa je mono- ili di-supstituirana s C 1-<br />
4alkilom i R 13 je H, C 1-6 alkil, opcionalno supstituiran s arilom, Het 1 , Het 2 ,<br />
hidroksidom, halogenom, aminom, gdje amino grupa može opcionalno<br />
biti mono- ili di-supstituirana s C 1-4 alkilom.<br />
(51) Int.Cl. C 07 D 239/30 7 (10) HR P20<strong>05</strong>0601 A2<br />
C 07 D 239/47<br />
C 07 D 239/48<br />
C 07 D 239/50<br />
C 07 D 401/12<br />
C 07 D 403/12<br />
C 07 D 403/14<br />
C 07 D 4<strong>05</strong>/12<br />
C 07 D 409/12<br />
C 07 D 411/12<br />
C 07 D 417/12<br />
C 07 D 417/14<br />
A 61 K 31/506<br />
A 61 P 35/02<br />
(21) P20<strong>05</strong>0601A (22) 28. 06.20<strong>05</strong>.<br />
(43) 31. 10.20<strong>05</strong>.<br />
(86) PCT/EP03/013443; 28. 11.2003.<br />
(87) WO04/048343; 10. 06.2004.<br />
(31) 02026607.8 (32) 28. 11.2002. (33) EP<br />
(54) PIRIMIDINI KOJI INHIBIRAJU CHK, PDK I AKT, NJIHOVA<br />
PROIZVODNJA I UPOTREBA KAO FARMACEUTSKIH<br />
SREDSTAVA<br />
CHK-, PDK-, AND AKT-INHIBITORY PYRIMIDINES, THEIR<br />
PRODUCTION AND USE AS PHARMARMACEUTICAL AGENTS<br />
(71) Schering AG, Müllerstrasse 178, 13353 Berlin, DE<br />
(72) Judi Bryant, 318 Via Recodo, Mill Valey, CA 94941, US<br />
Monica Kochanny, 590 East J Street, Bencia, CA 94510, US<br />
Shendong Yuan, 708 Forest Run, Hercules, CA 94547, US<br />
Seock-Kyu Khim, 148 Overlook Terrance, Hercules, CA 94547, US<br />
Brad Buckman, 2042 Leimert Blvd., Oakland, CA 94602, US<br />
Damian Arnaiz, 103 Bedford, 94547 Hercules, CA, US<br />
Ulf Bömer, Leipziger Strasse 49, 16548 Glienicke/Nordbahn, DE<br />
Hans Briem, Baumhauser Weg 41a, 28279 Bremen, DE<br />
Peter Esperling, Furastrasse 15c, 12107 Berlin, DE<br />
Christoph Huwe, Sandhauser Strasse 111, 135<strong>05</strong> Berlin, DE<br />
Joachim Kuhnke, Schlegelstrasse 2, 14469 Berlin, DE<br />
Martina Schäfer, Ossietzkystrasse 7, 13583 Berlin, DE<br />
Lars Wortmann, Rockenhauser Strasse 11, 13583 Berlin, DE<br />
Dirk Kosemund, Ulan-Baton-Strasse 51, 99091 Erfurt, DE<br />
Emil Eckle, Strudelstrasse 41, 73329 Kuchen, DE<br />
Richard Feldmann, 100 Pompona Avenue, El Cerrito, CA 94530,<br />
US<br />
Gary Phillips, 3043 Shetland Drive, Pleasant Hill, CA 94523, US<br />
(74) Dragutin Sikirić, Zagreb, HR<br />
(57)<br />
Ovaj se izum odnosi na derivate pirimidina opće formule (I) kao inhibitore<br />
kinaza, na njihovu proizvodnju kao i na njihovu upotrebu kao lijekova za<br />
tretiranje raznih bolesti.<br />
(51) Int.Cl. C 07 D 239/46 7 (10) HR P20031042 A2<br />
C 07 D 401/12<br />
A 61 K 31/506<br />
A 61 P 25/28<br />
(21) P20031042A (22) 16. 12.2003.<br />
(43) 31. 10.20<strong>05</strong>.<br />
(86) PCT/IB02/02261; 17. 06.2002.<br />
(87) WO03/000663; 03. 01.2003.<br />
(31) 60/299,953 (32) 21. 06.2001. (33) US<br />
(54) LIGANDI 5-HT RECEPTORA I NJIHOVE UPOTREBE<br />
5-HT RECEPTOR LIGANDS AND USES THEREOF<br />
(71) Pfizer Products Inc., Eastern Point Road, Groton, CT 06340, US<br />
(72) Yuan-Ching Phoebe Chiang, Pfizer Global Research and<br />
Development, Eastern Point Road, Groton, CT 06340, US<br />
William Albert Novomisle, Pfizer Global Research and<br />
Development, Eastern Point Road, Groton, CT 06340, US<br />
Willard McKowan Welch, Pfizer Global Research and Development,<br />
Eastern Point Road, Groton, CT 06340, US<br />
(74) Hraste & Partneri odvjetničko društvo, Zagreb, HR<br />
(57) U ovoj specifikaciji opisani su spojevi Formule (IA) koji djeluju kao<br />
ligandi 5-HT receptora i njihove upotrebe u liječenju bolesti povezanih s<br />
aktivacijom receptora 5-HT 2 kod životinja.<br />
(51) Int.Cl. C 07 D 239/48 7 (10) HR P20031081 A2<br />
A 61 K 31/5<strong>05</strong><br />
A 61 K 31/506<br />
A 61 P 35/00<br />
C 07 D 239/47<br />
C 07 D 239/34<br />
C 07 D 239/42<br />
C 07 D 4<strong>05</strong>/12<br />
C 07 D 401/12<br />
C 07 D 403/12<br />
C 07 D 409/12<br />
C 07 D 417/12<br />
(21) P20031081A (22) 23. 12.2003.<br />
(43) 31. 10.20<strong>05</strong>.<br />
(86) PCT/EP02/<strong>05</strong>669; 23. <strong>05</strong>.2002.<br />
(87) WO02/096888; <strong>05</strong>. 12.2002.<br />
(31) DE 101 27 581.1 (32) 29. <strong>05</strong>.2001. (33) DE<br />
DE 102 12 098.6 11. 03.2002. DE<br />
(54) CDK INHIBITORNI PIRIMIDINI, NJIHOVA PROIZVODNJA I<br />
PRIMJENA KAO LIJEKOVA<br />
CDK INHIBITING PYRIMIDINES, PRODUCTION THEREOF AND<br />
THEIR USE AS MEDICAMENTS<br />
(71) Schering Aktiengesellschaft, Müllerstrasse 178, 13342 Berlin, DE<br />
(72) Thomas Brumby, Lepsiusstrasse 60, 12163 Berlin, DE<br />
Rolf Jautelat, Driesenerstrasse 1, 10439 Berlin, DE<br />
Olaf Prien, Lützenstrasse 12, 10711 Berlin, DE<br />
Martina Schäfer, Ossietzystrasse 7, 13187 Berlin, DE<br />
Gerhard Siemeister, Reimerswalder Steig 26, 13503 Berlin, DE<br />
Urlich Lücking, Bergstrasse 62, 11115 Berlin, DE<br />
Christoph Huwe, Sandhauser Strasse 111, 135<strong>05</strong> Berlin, DE<br />
(74) Dragutin Sikirić, Zagreb, HR<br />
(57) Izum koji se predlaže odnosi se na derivate pirimidina opće formule<br />
(I) gdje se R 1 , R 2 , X, A i B definiraju kako je opisano, a koji se koriste kao<br />
inhibitori o ciklinu ovisnoj kinazi. Izum se dalje odnosi i na proizvodnju<br />
ovih spojeva u svrhu njihove primjene u liječenju raznih bolesti.<br />
(51) Int.Cl. C 07 D 239/91 7 (10) HR P20<strong>05</strong><strong>05</strong>20 A2<br />
C 07 D 279/16<br />
C 07 D 413/04<br />
C 07 D 265/38<br />
C 07 D 209/86<br />
C 07 D 215/14<br />
C 07 D 209/08<br />
C 07 D 213/30<br />
C 07 D 207/32<br />
C 07 D 235/06<br />
C 07 D 409/04<br />
C 07 D 261/08<br />
C 07 D 4<strong>05</strong>/04<br />
A 61 K 31/421<br />
A 61 K 31/422<br />
A 61 K 31/47<br />
A 61 K 31/358<br />
A 61 K 31/4439<br />
C 07 C 43/03<br />
A 61 P 3/10<br />
(21) P20<strong>05</strong><strong>05</strong>20A (22) 09. 06.20<strong>05</strong>.<br />
(43) 31. 10.20<strong>05</strong>.<br />
(86) PCT/IN03/000358; 14. 11.2003.<br />
(87) WO04/046119; 03. 06.2004.<br />
(31) 792/MUM/2003 (32) 12. 08.2003. (33) IN<br />
992/MUM/2002 15. 11.2002. IN<br />
(54) SUPSTITUIRANI AKRILNI DERIVATI<br />
SUBSTITUTED ARALKYL DERIVATIVES<br />
(71) Cadila Healthcare Limited, Zydus Tower, Satellite Cross Roads,<br />
Ahmedabad 380 015 Gujarat, IN<br />
(72) Braj, Bhushan Lohray, Zydus Tower, Satellite Cross Roads,<br />
ISSN 1331-2030